Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02813434
PHASE3
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
Sponsor: Centre Hospitalier Universitaire, Amiens
View on ClinicalTrials.gov
Summary
This study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia
Official title: Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2014-09-24
Completion Date
2025-01-07
Last Updated
2026-06-11
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
florbetapir
18F-AV-45 or 18F-Florbetapir
Locations (1)
CHU Amiens
Amiens, France